Telesis Bio, Inc.
TBIO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1% | -54.9% | -50.7% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 64.4% | -51.5% | 7.9% | 58.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -298.7% | -680.3% | -210.6% | -229.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -424.1% | -811.9% | -251.1% | -253.5% |
| EPS Diluted | -3.83 | -7.62 | -0.29 | -0.59 |
| % Growth | 49.7% | -2,527.6% | 50.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |